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Surgical TechniquesPostoperative Course
The patient’s condition stabilized, and sedation was dis-
continued the first postoperative day. The patient was free of
inotropic support on day 3 and was successfully extubated.
He showed no neurologic abnormalities and no rhythm dis-
orders. The patient was discharged 20 days postoperatively,
and he was alive and well (New York Heart Association
functional class II) on postoperative day 61.
DISCUSSION
Transcatheter aortic valve implantation as a treatment op-
tion for severe aortic valve stenosis has been a major devel-
opment in cardiovascular medicine of the last 5 years and
has become a routine procedure at many hospitals. Recent
studies have shown encouraging results, especially consid-
ering the high-risk population that has been treated.1,2
Concomitant treatment of coronary artery disease by
percutaneous intervention has been described.3 In addition,
single cases or small series of transcatheter mitral valve-in-
valve procedures, as well as 1 double valve procedure, have
been reported.4,5 The combination of all these procedures,
however, has never before been successfully performed.
The case presented here was thoroughly discussed by
a heart team after conventional surgery was denied. All
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procedure. It was, however, considered the least risky
option for the patient. There was also general agreement
that treating only some of the problems did not have
sufficient potential for symptom relief and might on the
contrary present a risk for slow postoperative recovery.
The procedural planning and conduct of this heart team
provides a good example of how treatment options can be
expanded for patients with a very high operative risk by
good collaboration between cardiologists and cardiac
surgeons.
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2011;59:490-2.Treatment of large subglottic tracheal schwannoma with
microdebrider bronchoscopyJose Melendez, MD,a Lorraine Cornwell, MD,b Linda Green, MD,c and Roberto F. Casal, MD,a Houston,
TexPrimary tracheal schwannomas are among the least com-
mon tracheal tumors.1 Although endoscopic treatment
with the Nd:YAG laser has been reported, surgical resection
remains the standard of care.2,3 We report here the
successful use of a novel bronchoscopic technique, themicrodebrider, for the management of a large subglottic
tracheal schwannoma.CLINICAL SUMMARY
A 63-year-old man was referred to our institution for
diagnosis and management of a large endotracheal mass
detected in a computed tomographic scan of the chest dur-
ing evaluation for dyspnea. We performed rigid bronchos-
copy, finding a mass on the posterior wall of the trachea,
2 cm from the vocal cords, with approximately 90%
obstruction of the lumen (Figure 1, A). This mass was ses-
sile, round, and broad based. Endobronchial ultrasonogra-
phy was used to assess the vascularity of the lesion and its
relationship to the esophagus, and to obtain a needle aspi-
ration specimen for preliminary diagnosis. On-site cyto-
logic examination showed a spindle cell tumor. The
patient was considered to be a poor surgical candidateery c August 2012
FIGURE 1. A, Large subglottic tracheal schwannoma obstructing 90% of the lumen. B, Straightshot M4Microdebrider, powered by the Integrated Power
Console (Medtronic, Inc, Minneapolis, Minn). C, Subglottic trachea after tumor debulking, showing no residual obstruction. D, Histopathologic examina-
tion, showing spindle cells staining strongly and diffusely positive for S-100, compatible with schwannoma.
Surgical Techniquesbecause of both comorbidities and the immediately sub-
glottic location of the lesion. Because ventilation and
oxygenation were suboptimal, we decided to debulk the
tumor with the Straightshot M4 Microdebrider, powered
by the Integrated Power Console (Medtronic, Inc, Minne-
apolis, Minn; Figure 1, B). Bleeding was minimal, and
there was no residual obstruction (Figure 1, C). The pa-
tient was successfully extubated, and his dyspnea was
resolved.
Within a few hours after the procedure, the patient had
trouble urinating and performed a prolonged Valsalva ma-
neuver, leading to mild pneumomediastinum. This pneumo-
mediastinum resolved spontaneously within 5 days, and the
patient was discharged. Immunohistochemical staining of
biopsy specimens was strongly and diffusely positive for
S-100, and the final diagnosis was benign schwannoma
(Figure 1, D). Follow-up at 3 and 6 months with chest com-
puted tomography and bronchoscopy showed no evidence
of tumor recurrence, and the patient has remained free of
symptoms.
DISCUSSION
Although the standard management of benign tracheal
schwannomas is circumferential resection with tracheal
reconstruction, bronchoscopic laser resection has also
been described.2,3 In our case, because of the large size
of his tumor and mild difficulty with ventilation andThe Journal of Thoracic and Caoxygenation during bronchoscopy, we chose to use
microdebrider bronchoscopy to recanalize the airway
swiftly. The microdebrider is a powered instrument
composed of a hollow metal tube with a rotating blade
coupled with suction that needs to be passed through
a rigid bronchoscope or tracheoscope.4 The metal tube
is 45 cm in length and 4 mm in diameter, with either
a straight or an angled tip (15). The handle of the micro-
debrider has a flywheel that allows 360 rotation of the tip.
After setting the rotation on the power source console,
a foot pedal is used to activate the blade. The rotation is
typically set at a rate of 1500 to 5000 rpm. The rotating
blade of the microdebrider should be gently placed in con-
tact with the tumor, allowing suction to bring the tumor
into it. The microdebrider can reach lesions in the trachea,
main stem bronchi, and bronchus intermedius. Unlike
with electrocautery techniques, lowering of inspired oxy-
gen fraction and interruptions in jet ventilation to avoid
endobronchial fire are not necessary. Additionally, the mi-
crodebrider does not need to be removed and reintroduced
for tumor debulking like most other bronchoscopic tools
(forceps, electrocautery probes), potentially shortening
the procedure time.
Although the microdebrider is a common tool for head
and neck specialists, its use in bronchoscopy is relatively
new, and data on effectiveness and safety are scant.4,5
Lunn and coworkers4 retrospectively described theirrdiovascular Surgery c Volume 144, Number 2 511
Surgical Techniquessuccessful and complication-free use of the microdebrider
in 23 patients with tracheal granulation tissue, idiopathic
subglottic stenosis, and malignant disease. There are no
available data regarding potential complications. Because
no hemostasis is provided with this technique, bleeding is
always a concern. Bleeding is generally mild, however,
and the suction of the microdebrider is strong enough to
keep the field clear. When bleeding is significant, a suction
catheter can be simultaneously introduced, or intermittent
electrocautery can be performed. Extra care is required
when debulking tumors arising in the posterior wall of the
trachea or main bronchi because of the risk of perforation.
The cost of the equipment is largely comparable to that of
other bronchoscopic tools used for tumor debulking. The
use of the microdebrider is intuitively obvious, and in our
opinion little training is needed for a thoracic surgeon or
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The microdebrider could become a valuable alternative
for the bronchoscopic management of tumors in the central
airways, particularly in cases of severe airway obstruction
causing suboptimal ventilation and oxygenation. Further
studies are needed to establish its safety profile.
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2007;2:16.A new technique for partial removal of the pulmonary artery in
video-assisted thoracic surgical lobectomyZhi Zhang, MD, Jianfeng Huang, MD, PhD, Rong Yin, MD, PhD, and Lin Xu, MD, PhD, Nanjing, ChinaLobectomy with video-assisted thoracic surgery (VATS) is
now popular worldwide and widely applied to patients
with early stage non–small cell lung cancer. Lobectomy
with pulmonary artery (PA) reconstruction by VATS cur-
rently remains a challenge for thoracic surgeons when the
PA is invaded by tumor or lymph nodes. In traditional
open thoracotomy, the surgical technique of clamping the
proximal PA and the pulmonary vein (PV) of the reserved
lobe is usually applied for PA reconstruction.1 We trans-
planted this idea into VATS and developed a new technique
for partial removal and reconstruction of the PA in VATS
lobectomy.
TECHNIQUE
Ethical approval for trial of VATS lobectomy with partial
removal and direct linear suture of the PA was obtainedfrom the institutional review board of the hospital. Between
December 2007 and August 2011, a total of 5 patients
agreed to undergo this procedure.
We placed an anterolateral minithoracotomy (40 mm) in
the fourth intercostal space. An access incision (12 mm)
was added for clamping of the PA in the third intercostal
space on the anterior–axillary line. Another 2 thoracoscopic
ports were placed in the seventh intercostal space on the
posterior–axillary line and the midaxillary line (Figure 1,
A). After the hilar dissection had been performed as previ-
ously reported,2 the PVand PA branches without cancer in-
vasion were stapled with vascular staplers. After the
superior PV had been divided to allow better viewing of
the PA, the proximal PA was controlled with a Satinsky
clamp. Specifically, on the right side the proximal control
was obtained anterior to the superior vena cava after divi-
sion of the truncus anterior of the PA; on the left side, it
was necessary to transect the ligamentum arteriosum to
clamp the PA trunk. A clamp was placed through the inci-
sion (third intercostal space) on the proximal PA after intra-
venous injection of 3125 U sodium heparin. Rather than
clamping the PV of the reserved lobe to avoid backflow,2
an umbilical tape was used to block the reserved PV and
was secured with a 5-mm Hem-o-lok clip (TeleflexMedical
Inc, Durham, NC), which can providemore space for the PA
reconstruction. The PA branches with cancer invasion wereery c August 2012
